Yongyuan Xiao
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neuroendocrine prostate cancer (NEPC)-associated CEP55 promotes cisplatin resistance in prostate cancer by regulating CDK1 phosphorylation.
Journal: Cancer pathogenesis and therapy
Published: April 02, 2025
Gut Parabacteroides distasonis-derived Indole-3-Acetic Acid Promotes Phospholipid Remodeling and Enhances Ferroptosis Sensitivity via the AhR-FASN Axis in Bladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 15, 2025
Burden disparities of genitourinary diseases among adults aged 55 and older in Europe: trends from 1990 to 2021 and projections to 2030: a cross-sectional study.
Journal: International journal of surgery (London, England)
Published: January 27, 2025
Global, regional, and national burden of genitourinary cancers in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.
Journal: Journal of the National Cancer Center
Published: September 11, 2024
Chimeric SFT2D2-TBX19 Promotes Prostate Cancer Progression by Encoding TBX19-202 Protein and Stabilizing Mitochondrial ATP Synthase through ATP5F1A Phosphorylation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 23, 2024
O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: May 18, 2024
CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.
Journal: Molecular cancer
Published: October 02, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026